| 1349 |
National Cancer Institute |
Html |
en |
Colon Cancer Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of colon cancer. |
| metastatic colorectal carcinoma | 0.379719 |
| Surg Oncol Clin | 0.28139 |
| Engl J Med | 0.307023 |
| trial | 0.267885 |
| Ann Surg | 0.318122 |
| colorectal cancer risk | 0.348524 |
| asymptomatic colorectal cancer | 0.315392 |
| metastatic colorectal cancer | 0.735027 |
| randomized phase | 0.263484 |
| colorectal metastasis | 0.289879 |
| colorectal cancer | 0.918186 |
| solitary colorectal liver | 0.301665 |
| progressive colorectal cancer | 0.31143 |
| Natl Cancer Inst | 0.281801 |
| colorectal metastases | 0.313181 |
| nonpolyposis colorectal carcinoma | 0.307382 |
| Clin Cancer Res | 0.283288 |
| refractory metastatic colorectal | 0.315102 |
| et al. | 0.431822 |
| familial colorectal cancer | 0.339414 |
| colorectal secondaries | 0.290645 |
| colorectal cancer patients | 0.339629 |
| colorectal liver metastases | 0.36614 |
| colorectal cancer survivors | 0.325228 |
|
| colorectal cancer-specific mortality | 0.322283 |
| untreated metastatic colorectal | 0.318138 |
| wild-type metastatic colorectal | 0.314285 |
| Colorectal carcinoma survival | 0.308216 |
| colorectal hepatic metastases | 0.334861 |
| advanced colorectal cancer | 0.418679 |
| Colorectal lung metastases | 0.315994 |
| irinotecan-refractory metastatic colorectal | 0.314278 |
| advanced colorectal carcinoma | 0.299668 |
| colon cancer patients | 0.266011 |
| recurrent colorectal cancer | 0.311799 |
| colorectal adenocarcinoma | 0.293617 |
| colorectal cancer incidence | 0.338171 |
| colorectal cancer disparities | 0.338169 |
| occult colorectal cancer | 0.324742 |
| colorectal cancer rates | 0.338223 |
| hepatic resection | 0.263128 |
| Colorectal Study Group | 0.29718 |
| Abstract | 0.463347 |
| colon cancer | 0.282697 |
| Clin Oncol | 0.692377 |
| colorectal carcinoma | 0.438634 |
| resection | 0.263133 |
| colorectal carcinoma metastases | 0.326025 |
|
CLICK HERE |
| 1471 |
National Cancer Institute |
Html |
en |
Small Intestine Cancer Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of small intestine cancer. |
| illustrations | 0.418999 |
| duodenum. | 0.42103 |
| PDQ cancer information | 0.903829 |
| resectable leiomyosarcoma | 0.536755 |
| PDQ information | 0.645092 |
| Small intestine carcinomas | 0.711426 |
| multiple sites | 0.521204 |
| scientific images | 0.511301 |
| malignant lesions | 0.542214 |
| text | 0.419438 |
| cancer information summary | 0.765692 |
| National Institutes | 0.515005 |
| sentence | 0.423056 |
| breast cancer prevention | 0.606867 |
| author | 0.434223 |
| NCI’s PDQ | 0.679179 |
| PDQ Adult Treatment | 0.75546 |
| adenocarcinomas | 0.421075 |
| NCI PDQ cancer | 0.783554 |
| carcinoid tumors | 0.53815 |
| small intestine | 0.82655 |
| jejunum | 0.420595 |
| ileum | 0.420633 |
| relates | 0.424246 |
| resectable adenocarcinoma | 0.544916 |
|
| 5-year survival rate | 0.903147 |
| common primary sarcoma | 0.632045 |
| content | 0.419494 |
| predominant modality | 0.550555 |
| literature | 0.41999 |
| overall 5-year survival | 0.674093 |
| National Cancer Institute | 0.792644 |
| trademark | 0.418975 |
| Editorial Board | 0.520308 |
| ability | 0.4195 |
| PDQ documents | 0.647487 |
| primary malignant tumors | 0.647543 |
| owner | 0.419281 |
| Visuals Online | 0.515575 |
| entirety | 0.426542 |
| Health | 0.419895 |
| cancer-related images | 0.526463 |
| permission | 0.44717 |
| NIH | 0.422847 |
| gastrointestinal malignancies | 0.551608 |
| resection | 0.436749 |
| duodenum | 0.432045 |
| policy statement | 0.518223 |
| independent review | 0.515819 |
|
CLICK HERE |
| 1500 |
National Cancer Institute |
Html |
en |
Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of non-small cell lung cancer. |
| Lung Cancer Cooperative | 0.310221 |
| lung carcinoma | 0.380451 |
| inoperable lung cancer | 0.309782 |
| early non-small-cell lung | 0.307115 |
| advanced non-small-cell lung | 0.469604 |
| Lung Cancer Study | 0.326026 |
| lung cancer | 0.971767 |
| Lung cancer deaths | 0.317514 |
| nonsquamous non-small-cell lung | 0.297343 |
| phase iii trial | 0.299266 |
| occult lung cancer | 0.305312 |
| early-stage lung cancer | 0.338843 |
| Radiat Oncol Biol | 0.304077 |
| lung cancer survival | 0.297734 |
| Lung Cancer Group | 0.321151 |
| initial lung cancer | 0.317764 |
| Natl Cancer Inst | 0.376584 |
| non-small cell lung | 0.774213 |
| resectable lung cancer | 0.304943 |
| Cochrane Database Syst | 0.296204 |
| inoperable non-small-cell lung | 0.308792 |
| non-small cell carcinoma | 0.303827 |
| extensive-stage non-small-cell lung | 0.295848 |
| non-small-cell lung carcinoma | 0.344111 |
| IIIB/IV non-small-cell lung | 0.298147 |
|
| et al. | 0.437141 |
| Lancet Oncol | 0.323758 |
| metastatic non-small-cell lung | 0.298496 |
| advanced non-small cell | 0.33334 |
| stage lung cancer | 0.3104 |
| nonsmall cell lung | 0.30317 |
| stage non-small-cell lung | 0.297284 |
| PUBMED Abstract | 0.329665 |
| Ann Thorac Surg | 0.373477 |
| Lung Cancer Vinorelbine | 0.296492 |
| Thorac Cardiovasc Surg | 0.329974 |
| lung cancer patients | 0.336644 |
| Cancer Lung Cancer | 0.319239 |
| Abstract | 0.497046 |
| Clin Oncol | 0.544028 |
| cell lung carcinoma | 0.373251 |
| Oncol Biol Phys | 0.305449 |
| lung cancer risk | 0.31701 |
| non-squamous non-small-cell lung | 0.296764 |
| cell lung cancer | 0.689155 |
| IIIB non-small-cell lung | 0.303595 |
| Clin Lung Cancer | 0.316476 |
| resected non-small-cell lung | 0.312654 |
| oncology group | 0.300833 |
|
CLICK HERE |
| 1551 |
National Cancer Institute |
Html |
null |
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of childhood acute myeloid leukemia, myelodysplastic syndromes, and other myeloproliferative disorders. |
|
|
CLICK HERE |
| 1567 |
National Cancer Institute |
Html |
en |
Metastatic Squamous Neck Cancer with Occult Primary Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of metastatic squamous neck cancer with occult primary. |
| cancer treatment | 0.331255 |
| neck muscles | 0.258524 |
| cancer spreads | 0.287607 |
| metastatic cancer | 0.293108 |
| malignant tumor cells | 0.281382 |
| body | 0.321816 |
| PDQ cancer information | 0.347021 |
| squamous cells | 0.294186 |
| clinical trial search | 0.272504 |
| external radiation treatment | 0.262886 |
| clinical trials | 0.659393 |
| cancer information summary | 0.31748 |
| clinical trial | 0.463543 |
| squamous cell cancer | 0.363064 |
| breast cancer prevention | 0.264993 |
| radical neck dissection | 0.322726 |
| patients | 0.300058 |
| earlier clinical trials | 0.261657 |
| treatment clinical trial | 0.277097 |
| PDQ Adult Treatment | 0.268031 |
| different types | 0.294996 |
| NCI PDQ cancer | 0.286254 |
| tests | 0.272201 |
| radiation therapy | 0.490196 |
| Treatment Editorial Board | 0.283384 |
|
| lung cancer cells | 0.288937 |
| currently used treatment | 0.262475 |
| metastatic squamous neck | 0.988686 |
| treatment | 0.481959 |
| Occult Primary Treatment | 0.275159 |
| new cancer treatments | 0.27464 |
| cancer cells | 0.387801 |
| Cancer Information Service | 0.273937 |
| PDQ Metastatic Squamous | 0.312989 |
| Hyperfractionated radiation therapy | 0.272771 |
| treatment clinical trials | 0.300592 |
| squamous neck cancer | 0.954253 |
| National Cancer Institute | 0.34026 |
| occult primary | 0.527765 |
| new treatment | 0.321855 |
| new treatments | 0.258619 |
| Cancer Care page | 0.264657 |
| primary tumor | 0.396235 |
| cancer research process | 0.267043 |
| cancer clinical trials | 0.302055 |
| treatment options | 0.305059 |
| cancer information summaries | 0.272694 |
| comprehensive cancer information | 0.272807 |
| occult primary tumor | 0.271623 |
|
CLICK HERE |
| 1656 |
National Cancer Institute |
Html |
null |
Last Days of Life (PDQ®)–Health Professional Version |
Expert-reviewed information summary about care during the last days to last hours of life, including common symptoms, ethical dilemmas that may arise, and the role of the oncologist in caring for patients and their families during this time. |
|
|
CLICK HERE |
| 1793 |
National Cancer Institute |
Html |
es |
La nutrición en el tratamiento del cáncer (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca de las causas y manejo de los problemas de nutrición que se presentan en pacientes de cáncer. |
| alimentos quizás | 0.370325 |
| PDQ Complicaciones | 0.313282 |
| siguientes procedimientos | 0.340481 |
| células madre | 0.550599 |
| nutrientes clave | 0.335265 |
| siguientes elementos | 0.365852 |
| siguientes aspectos | 0.358365 |
| nutriciónLa terapia | 0.324031 |
| siguientes especialistas | 0.336855 |
| abundantes calorÃas | 0.314309 |
| azúcar morena | 0.306423 |
| apoyo nutricional parenteral | 0.676801 |
| alimentos nombre | 0.30449 |
| plantas crucÃferas | 0.309965 |
| nutriciónLos pacientes | 0.345324 |
| siguientes preguntas | 0.30436 |
| folleto consejos | 0.305431 |
| saliva espesa | 0.32646 |
| dentaduras postizas | 0.314487 |
| suficiente aire | 0.303863 |
| La nutrición | 0.791013 |
| paciente coma | 0.327504 |
| parenteralLa nutrición parenteral | 0.367865 |
|
| nutriciónLa radioterapia | 0.32699 |
| Nutrición enteralLa | 0.344949 |
| Fideos macarrones | 0.304814 |
| paciente debilidad | 0.352763 |
| nutriciónLa quimioterapia | 0.324928 |
| siguientes problemas | 0.328941 |
| abundantes proteÃnas | 0.312201 |
| abundante cantidad | 0.303969 |
| pequeñas cantidades | 0.366387 |
| suficientes calorÃas | 0.337397 |
| sección boca | 0.313815 |
| queso crema | 0.306383 |
| suficientes proteÃnas | 0.348155 |
| suficientes alimentos | 0.437599 |
| suficientes nutrientes | 0.304871 |
| estado nutricional ayuda | 0.362928 |
| huevos rellenos | 0.30608 |
| siguientes logros | 0.337047 |
| nutrición parenteral | 0.929054 |
| horarios fijos | 0.305496 |
| siguientes propósitos | 0.338729 |
| cuidado paliativo | 0.310231 |
|
CLICK HERE |
| 1815 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de cuello uterino (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del cáncer de cuello uterino. |
| Obstet Gynecol | 0.42996 |
| stage iib-iva carcinoma | 0.404466 |
| Massad LS | 0.404333 |
| cervical carcinoma | 0.464118 |
| Bundy BN | 0.406109 |
| adenosquamous carcinomas | 0.405376 |
| Radiat Oncol Biol | 0.406797 |
| stage ib | 0.417647 |
| oncology group study | 0.410713 |
| Natl Cancer Inst | 0.438413 |
| cervical cancer | 0.632715 |
| advanced cervical carcinoma | 0.414377 |
| stage ib squamous | 0.405131 |
| Gynecologic Oncology Group | 0.426077 |
| Cervical stump carcinoma | 0.407575 |
| Gynecol Oncol | 0.448646 |
| patients with | 0.420179 |
| human papillomavirus | 0.464727 |
| early invasive carcinoma | 0.40349 |
| IB cervical carcinoma | 0.422999 |
| Lancet Oncol | 0.403538 |
| Castle PE | 0.404079 |
| adenosquamous cell carcinoma | 0.403688 |
| cervical cytology | 0.405121 |
| cervical smears as | 0.405304 |
|
| estadio ia | 0.405069 |
| squamous cell | 0.407969 |
| cervical carcinoma from | 0.408556 |
| Féderation Internationale | 0.404624 |
| Human papillomavirus type | 0.404678 |
| Cancer Institute Workshop | 0.403618 |
| cervix treated with | 0.403584 |
| estadio ia2 | 0.404118 |
| medically inoperable carcinoma | 0.403293 |
| patients with stage | 0.411753 |
| Clin Oncol | 0.421471 |
| invasive cervical carcinoma | 0.408099 |
| cervical cancers studied | 0.405438 |
| Cervical Cancer Meta-Analysis | 0.408283 |
| Oncol Biol Phys | 0.406905 |
| with cervical carcinoma | 0.410366 |
| cervix with negative | 0.403324 |
| cervical intraepithelial neoplasia | 0.500035 |
| cuello uterino | 0.989011 |
| squamous intraepithelial lesions | 0.406344 |
| treated with | 0.404461 |
| locally advanced | 0.404236 |
| Wright TC Jr | 0.413972 |
| AJCC Cancer Staging | 0.403712 |
|
CLICK HERE |
| 1866 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de labio y de cavidad oral (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del cáncer de labio y de cavidad oral. |
| adjuvant chemotherapy | 0.438971 |
| Sin embargo | 0.43685 |
| tumor volume measurements | 0.41592 |
| Neck Neoplasms | 0.440866 |
| Merlano M | 0.418057 |
| advanced squamous | 0.428154 |
| inoperable squamous | 0.435102 |
| Arch Otolaryngol Head | 0.440314 |
| Radiat Oncol Biol | 0.538084 |
| Multidisciplinary Approach | 0.478999 |
| Natl Cancer Inst | 0.426444 |
| with cisplatin-containing combination | 0.417426 |
| neck squamous carcinoma | 0.461751 |
| radiation therapy | 0.439011 |
| Head Neck Surg | 0.5075 |
| superficial oral carcinoma | 0.418551 |
| final report | 0.416402 |
| Hong WK | 0.508707 |
| Ensley J | 0.418135 |
| with radiotherapy | 0.424203 |
| Head Neck | 0.61126 |
| neck squamous-cell carcinoma | 0.450172 |
| Kish J | 0.417112 |
| Neck Contracts Program | 0.437615 |
| radioterapia posoperatoria | 0.454665 |
|
| Oral Oncol | 0.423046 |
| Otolaryngol Head Neck | 0.504953 |
| >2 cm | 0.426493 |
| postoperative radiotherapy | 0.416731 |
| oral cavity squamous | 0.417165 |
| lesiones t2 | 0.432316 |
| múltiples ganglios | 0.422477 |
| initially with cisplatin-containing | 0.416896 |
| New York | 0.427836 |
| Clin Oncol | 0.536205 |
| Oncol Biol Phys | 0.544158 |
| Sessions RB | 0.479303 |
| locally advanced squamous | 0.426072 |
| cisplatin-containing combination chemotherapy | 0.424671 |
| Neck Surgery | 0.456161 |
| Combined chemotherapy | 0.419622 |
| neck cancer | 0.956394 |
| treated initially with | 0.417222 |
| unresectable squamous | 0.416233 |
| oral cavity | 0.51028 |
| versus concomitant treatment | 0.418958 |
| locally advanced | 0.441621 |
| neck cancers treated | 0.438026 |
| induction chemotherapy | 0.428539 |
|
CLICK HERE |
| 16258 |
National Cancer Institute |
Html |
es |
Exámenes de detección y detección temprana |
El NCI apoya y dirige investigación sobre exámenes de detección y detección temprana de cáncer, incluyendo estudios para formular y validar marcadores biológicos. |
| Estados Unidos. | 0.305194 |
| cabo extensión | 0.305776 |
| Investigación Oncológica | 0.305832 |
| Mejor cuantificación | 0.307132 |
| amplia variedad | 0.306584 |
| Estados Unidos | 0.358649 |
| causarán sÃntomas | 0.306983 |
| cáncer colorrectal | 0.434511 |
| cabo análisis | 0.306294 |
| memorable estudio nacional | 0.309583 |
|
| sobretratamiento—el diagnóstico | 0.307579 |
| socioeconómicos especÃficos—que | 0.307995 |
| gente—con frecuencia | 0.307545 |
| cabo el NCI | 0.307119 |
| Mejor detección | 0.335532 |
| factores genéticos causantes | 0.312309 |
| El Programa Nacional Comunitario | 0.309532 |
| Nuevas tecnologÃas | 0.306404 |
| detección temprana | 0.979153 |
|
CLICK HERE |